This work is licensed under the Creative Commons Attribution 4.0 International License.
Ziaeian B and Fonarow GC. Epidemiology and aetiology of heart failure. Nat Rev Cardiol. 2016;13:368–78.ZiaeianBFonarowGCEpidemiology and aetiology of heart failure2016133687810.1038/nrcardio.2016.25486877926935038Search in Google Scholar
Brown DA, Perry JB, Allen ME, Sabbah HN, Stauffer BL, Shaikh SR, Cleland JG, Colucci WS, Butler J, Voors AA, Anker SD, Pitt B, Pieske B, Filippatos G, Greene SJ and Gheorghiade M. Expert consensus document: Mitochondrial function as a therapeutic target in heart failure. Nat Rev Cardiol. 2017;14:238–250.BrownDAPerryJBAllenMESabbahHNStaufferBLShaikhSRClelandJGColucciWSButlerJVoorsAAAnkerSDPittBPieskeBFilippatosGGreeneSJGheorghiadeMExpert consensus document: Mitochondrial function as a therapeutic target in heart failure20171423825010.1038/nrcardio.2016.203535003528004807Search in Google Scholar
Writing Group M, Mozaffarian D, Benjamin EJ, Go AS, Arnett DK, Blaha MJ, Cushman M, Das SR, de Ferranti S, Despres JP, Fullerton HJ, Howard VJ, Huffman MD, Isasi CR, Jimenez MC, Judd SE, Kissela BM, Lichtman JH, Lisabeth LD, Liu S, Mackey RH, Magid DJ, McGuire DK, Mohler ER, 3rd, Moy CS, Muntner P, Mussolino ME, Nasir K, Neumar RW, Nichol G, Palaniappan L, Pandey DK, Reeves MJ, Rodriguez CJ, Rosamond W, Sorlie PD, Stein J, Towfighi A, Turan TN, Virani SS, Woo D, Yeh RW, Turner MB, American Heart Association Statistics C and Stroke Statistics S. Heart Disease and Stroke Statistics-2016 Update: A Report From the American Heart Association. Circulation. 2016;133:e38–360.Writing Group MMozaffarianDBenjaminEJGoASArnettDKBlahaMJCushmanMDasSRde FerrantiSDespresJPFullertonHJHowardVJHuffmanMDIsasiCRJimenezMCJuddSEKisselaBMLichtmanJHLisabethLDLiuSMackeyRHMagidDJMcGuireDKMohlerER3rdMoyCSMuntnerPMussolinoMENasirKNeumarRWNicholGPalaniappanLPandeyDKReevesMJRodriguezCJRosamondWSorliePDSteinJTowfighiATuranTNViraniSSWooDYehRWTurnerMBAmerican Heart Association Statistics C and Stroke Statistics SHeart Disease and Stroke Statistics-2016 Update: A Report From the American Heart Association2016133e3836010.1161/CIR.000000000000035026673558Search in Google Scholar
Nagueh SF, Smiseth OA, Appleton CP, Byrd BF, 3rd, Dokainish H, Edvardsen T, Flachskampf FA, Gillebert TC, Klein AL, Lancellotti P, Marino P, Oh JK, Alexandru Popescu B, Waggoner AD, Houston T, Oslo N, Phoenix A, Nashville T, Hamilton OC, Uppsala S, Ghent, Liege B, Cleveland O, Novara I, Rochester M, Bucharest R and St. Louis M. Recommendations for the Evaluation of Left Ventricular Diastolic Function by Echocardiography: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging. 2016;17:1321–1360.NaguehSFSmisethOAAppletonCPByrdBF3rdDokainishHEdvardsenTFlachskampfFAGillebertTCKleinALLancellottiPMarinoPOhJKAlexandru PopescuBWaggonerADHoustonTOsloNPhoenixANashvilleTHamiltonOCUppsalaSGhentLiegeBClevelandONovaraIRochesterMBucharestRSt. LouisMRecommendations for the Evaluation of Left Ventricular Diastolic Function by Echocardiography: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging2016171321136010.1093/ehjci/jew08227422899Search in Google Scholar
De Jong KA and Lopaschuk GD. Complex Energy Metabolic Changes in Heart Failure With Preserved Ejection Fraction and Heart Failure With Reduced Ejection Fraction. Can J Cardiol. 2017;33:860–871.De JongKALopaschukGDComplex Energy Metabolic Changes in Heart Failure With Preserved Ejection Fraction and Heart Failure With Reduced Ejection Fraction20173386087110.1016/j.cjca.2017.03.00928579160Search in Google Scholar
Stanley WC, Recchia FA and Lopaschuk GD. Myocardial substrate metabolism in the normal and failing heart. Physiol Rev. 2005;85:1093–129.StanleyWCRecchiaFALopaschukGDMyocardial substrate metabolism in the normal and failing heart200585109312910.1152/physrev.00006.200415987803Search in Google Scholar
Barth AS, Kumordzie A, Frangakis C, Margulies KB, Cappola TP and Tomaselli GF. Reciprocal transcriptional regulation of metabolic and signaling pathways correlates with disease severity in heart failure. Circ Cardiovasc Genet. 2011;4:475–83.BarthASKumordzieAFrangakisCMarguliesKBCappolaTPTomaselliGFReciprocal transcriptional regulation of metabolic and signaling pathways correlates with disease severity in heart failure201144758310.1161/CIRCGENETICS.110.957571339880521828333Search in Google Scholar
Senni M, Gavazzi A, Gheorghiade M and Butler J. Heart failure at the crossroads: moving beyond blaming stakeholders to targeting the heart. Eur J Heart Fail. 2015;17:760–3.SenniMGavazziAGheorghiadeMButlerJHeart failure at the crossroads: moving beyond blaming stakeholders to targeting the heart201517760310.1002/ejhf.31526179815Search in Google Scholar
Bayeva M, Sawicki KT and Ardehali H. Taking diabetes to heart—deregulation of myocardial lipid metabolism in diabetic cardiomyopathy. Journal of the American Heart Association. 2013;2:e000433.BayevaMSawickiKTArdehaliHTaking diabetes to heart—deregulation of myocardial lipid metabolism in diabetic cardiomyopathy20132e00043310.1161/JAHA.113.000433388673824275630Search in Google Scholar
Puchalska P and Crawford PA. Multi-dimensional Roles of Ketone Bodies in Fuel Metabolism, Signaling, and Therapeutics. Cell metabolism. 2017;25:262–284.PuchalskaPCrawfordPAMulti-dimensional Roles of Ketone Bodies in Fuel Metabolism, Signaling, and Therapeutics20172526228410.1016/j.cmet.2016.12.022531303828178565Search in Google Scholar
Abel ED. Glucose transport in the heart. Front Biosci. 2004;9:201–15.AbelEDGlucose transport in the heart200492011510.2741/1216Search in Google Scholar
Kerner J and Hoppel C. Fatty acid import into mitochondria. Biochim Biophys Acta. 2000;1486:1–17.KernerJHoppelCFatty acid import into mitochondria2000148611710.1016/S1388-1981(00)00044-5Search in Google Scholar
Cook GA, Lavrentyev EN, Pham K and Park EA. Streptozotocin diabetes increases mRNA expression of ketogenic enzymes in the rat heart. Biochimica et biophysica acta. 2017;1861:307–312.CookGALavrentyevENPhamKParkEAStreptozotocin diabetes increases mRNA expression of ketogenic enzymes in the rat heart2017186130731210.1016/j.bbagen.2016.11.012536282427845231Search in Google Scholar
Sun W, Quan N, Wang L, Yang H, Chu D, Liu Q, Zhao X, Leng J and Li J. Cardiac-Specific Deletion of the Pdha1 Gene Sensitizes Heart to Toxicological Actions of Ischemic Stress. Toxicol Sci. 2016;153:411.SunWQuanNWangLYangHChuDLiuQZhaoXLengJLiJCardiac-Specific Deletion of the Pdha1 Gene Sensitizes Heart to Toxicological Actions of Ischemic Stress201615341110.1093/toxsci/kfw154628088927605416Search in Google Scholar
Abel ED, Kaulbach HC, Tian R, Hopkins JC, Duffy J, Doetschman T, Minnemann T, Boers ME, Hadro E, Oberste-Berghaus C, Quist W, Lowell BB, Ingwall JS and Kahn BB. Cardiac hypertrophy with preserved contractile function after selective deletion of GLUT4 from the heart. The Journal of clinical investigation. 1999;104:1703–14.AbelEDKaulbachHCTianRHopkinsJCDuffyJDoetschmanTMinnemannTBoersMEHadroEOberste-BerghausCQuistWLowellBBIngwallJSKahnBBCardiac hypertrophy with preserved contractile function after selective deletion of GLUT4 from the heart199910417031410.1172/JCI760540988110606624Search in Google Scholar
Anderson EJ, Kypson AP, Rodriguez E, Anderson CA, Lehr EJ and Neufer PD. Substrate-specific derangements in mitochondrial metabolism and redox balance in the atrium of the type 2 diabetic human heart. J Am Coll Cardiol. 2009;54:1891–8.AndersonEJKypsonAPRodriguezEAndersonCALehrEJNeuferPDSubstrate-specific derangements in mitochondrial metabolism and redox balance in the atrium of the type 2 diabetic human heart2009541891810.1016/j.jacc.2009.07.031280013019892241Search in Google Scholar
Anderson EJ, Lustig ME, Boyle KE, Woodlief TL, Kane DA, Lin CT, Price JW, 3rd, Kang L, Rabinovitch PS, Szeto HH, Houmard JA, Cortright RN, Wasserman DH and Neufer PD. Mitochondrial H2O2 emission and cellular redox state link excess fat intake to insulin resistance in both rodents and humans. J Clin Invest. 2009;119:573–81.AndersonEJLustigMEBoyleKEWoodliefTLKaneDALinCTPriceJW3rdKangLRabinovitchPSSzetoHHHoumardJACortrightRNWassermanDHNeuferPDMitochondrial H2O2 emission and cellular redox state link excess fat intake to insulin resistance in both rodents and humans20091195738110.1172/JCI37048264870019188683Search in Google Scholar
Aon MA, Tocchetti CG, Bhatt N, Paolocci N and Cortassa S. Protective mechanisms of mitochondria and heart function in diabetes. Antioxid Redox Signal. 2015;22:1563–86.AonMATocchettiCGBhattNPaolocciNCortassaSProtective mechanisms of mitochondria and heart function in diabetes20152215638610.1089/ars.2014.6123444963025674814Search in Google Scholar
Bayeva M, Sawicki KT and Ardehali H. Taking diabetes to heart–deregulation of myocardial lipid metabolism in diabetic cardiomyopathy. J Am Heart Assoc. 2013;2:e000433.BayevaMSawickiKTArdehaliHTaking diabetes to heart–deregulation of myocardial lipid metabolism in diabetic cardiomyopathy20132e00043310.1161/JAHA.113.000433388673824275630Search in Google Scholar
Rosca MG, Tandler B and Hoppel CL. Mitochondria in cardiac hypertrophy and heart failure. J Mol Cell Cardiol. 2013;55:31–41.RoscaMGTandlerBHoppelCLMitochondria in cardiac hypertrophy and heart failure201355314110.1016/j.yjmcc.2012.09.002380505022982369Search in Google Scholar
Rosca MG and Hoppel CL. Mitochondrial dysfunction in heart failure. Heart Fail Rev. 2013;18:607–22.RoscaMGHoppelCLMitochondrial dysfunction in heart failure2013186072210.1007/s10741-012-9340-0385529122948484Search in Google Scholar
Lai L, Leone TC, Zechner C, Schaeffer PJ, Kelly SM, Flanagan DP, Medeiros DM, Kovacs A and Kelly DP. Transcriptional coactivators PGC-1alpha and PGC-lbeta control overlapping programs required for perinatal maturation of the heart. Genes Dev. 2008;22:1948–61.LaiLLeoneTCZechnerCSchaefferPJKellySMFlanaganDPMedeirosDMKovacsAKellyDPTranscriptional coactivators PGC-1alpha and PGC-lbeta control overlapping programs required for perinatal maturation of the heart20082219486110.1101/gad.1661708249274018628400Search in Google Scholar
Lehman JJ, Barger PM, Kovacs A, Saffitz JE, Medeiros DM and Kelly DP. Peroxisome proliferator-activated receptor gamma coactivator-1 promotes cardiac mitochondrial biogenesis. J Clin Invest. 2000;106:847–56.LehmanJJBargerPMKovacsASaffitzJEMedeirosDMKellyDPPeroxisome proliferator-activated receptor gamma coactivator-1 promotes cardiac mitochondrial biogenesis20001068475610.1172/JCI1026851781511018072Search in Google Scholar
Sack MN, Rader TA, Park S, Bastin J, McCune SA and Kelly DP. Fatty acid oxidation enzyme gene expression is downregulated in the failing heart. Circulation. 1996;94:2837–42.SackMNRaderTAParkSBastinJMcCuneSAKellyDPFatty acid oxidation enzyme gene expression is downregulated in the failing heart19969428374210.1161/01.CIR.94.11.28378941110Search in Google Scholar
Sihag S, Cresci S, Li AY, Sucharov CC and Lehman JJ. PGC-1alpha and ERRalpha target gene downregulation is a signature of the failing human heart. J Mol Cell Cardiol. 2009;46:201–12.SihagSCresciSLiAYSucharovCCLehmanJJPGC-1alpha and ERRalpha target gene downregulation is a signature of the failing human heart2009462011210.1016/j.yjmcc.2008.10.025268126519061896Search in Google Scholar
Goikoetxea MJ, Beaumont J, Gonzalez A, Lopez B, Querejeta R, Larman M and Diez J. Altered cardiac expression of peroxisome proliferator-activated receptor-isoforms in patients with hypertensive heart disease. Cardiovasc Res. 2006;69:899–907.GoikoetxeaMJBeaumontJGonzalezALopezBQuerejetaRLarmanMDiezJAltered cardiac expression of peroxisome proliferator-activated receptor-isoforms in patients with hypertensive heart disease20066989990710.1016/j.cardiores.2005.11.01616371224Search in Google Scholar
Lapuente-Brun E, Moreno-Loshuertos R, Acin-Perez R, Latorre-Pellicer A, Colas C, Balsa E, Perales-Clemente E, Quiros PM, Calvo E, Rodriguez-Hernandez MA, Navas P, Cruz R, Carracedo A, Lopez-Otin C, Perez-Martos A, Fernandez-Silva P, Fernandez-Vizarra E and Enriquez JA. Supercomplex assembly determines electron flux in the mitochondrial electron transport chain. Science. 2013;340:1567–70.Lapuente-BrunEMoreno-LoshuertosRAcin-PerezRLatorre-PellicerAColasCBalsaEPerales-ClementeEQuirosPMCalvoERodriguez-HernandezMANavasPCruzRCarracedoALopez-OtinCPerez-MartosAFernandez-SilvaPFernandez-VizarraEEnriquezJASupercomplex assembly determines electron flux in the mitochondrial electron transport chain201334015677010.1126/science.123038123812712Search in Google Scholar
Rosca MG, Vazquez EJ, Kerner J, Parland W, Chandler MP, Stanley W, Sabbah HN and Hoppel CL. Cardiac mitochondria in heart failure: decrease in respirasomes and oxidative phosphorylation. Cardiovasc Res. 2008;80:30–9.RoscaMGVazquezEJKernerJParlandWChandlerMPStanleyWSabbahHNHoppelCLCardiac mitochondria in heart failure: decrease in respirasomes and oxidative phosphorylation20088030910.1093/cvr/cvn184253342318710878Search in Google Scholar
Rosca M, Minkler P and Hoppel CL. Cardiac mitochondria in heart failure: normal cardiolipin profile and increased threonine phosphorylation of complex IV. Biochim Biophys Acta. 2011;1807:1373–82.RoscaMMinklerPHoppelCLCardiac mitochondria in heart failure: normal cardiolipin profile and increased threonine phosphorylation of complex IV2011180713738210.1016/j.bbabio.2011.02.00321320465Search in Google Scholar
Pfeiffer K, Gohil V, Stuart RA, Hunte C, Brandt U, Greenberg ML and Schagger H. Cardiolipin stabilizes respiratory chain supercomplexes. J Biol Chem. 2003;278:52873–80.PfeifferKGohilVStuartRAHunteCBrandtUGreenbergMLSchaggerHCardiolipin stabilizes respiratory chain supercomplexes2003278528738010.1074/jbc.M30836620014561769Search in Google Scholar
McKenzie M, Lazarou M, Thorburn DR and Ryan MT. Mitochondrial respiratory chain supercomplexes are destabilized in Barth Syndrome patients. J Mol Biol. 2006;361:462–9.McKenzieMLazarouMThorburnDRRyanMTMitochondrial respiratory chain supercomplexes are destabilized in Barth Syndrome patients2006361462910.1016/j.jmb.2006.06.057Search in Google Scholar
Lesnefsky EJ, Chen Q, Slabe TJ, Stoll MS, Minkler PE, Hassan MO, Tandler B and Hoppel CL. Ischemia, rather than reperfusion, inhibits respiration through cytochrome oxidase in the isolated, perfused rabbit heart: role of cardiolipin. Am J Physiol Heart Circ Physiol. 2004;287:H258–67.LesnefskyEJChenQSlabeTJStollMSMinklerPEHassanMOTandlerBHoppelCLIschemia, rather than reperfusion, inhibits respiration through cytochrome oxidase in the isolated, perfused rabbit heart: role of cardiolipin2004287H2586710.1152/ajpheart.00348.2003Search in Google Scholar
Sparagna GC, Chicco AJ, Murphy RC, Bristow MR, Johnson CA, Rees ML, Maxey ML, McCune SA and Moore RL. Loss of cardiac tetralinoleoyl cardiolipin in human and experimental heart failure. J Lipid Res. 2007;48:1559–70.SparagnaGCChiccoAJMurphyRCBristowMRJohnsonCAReesMLMaxeyMLMcCuneSAMooreRLLoss of cardiac tetralinoleoyl cardiolipin in human and experimental heart failure20074815597010.1194/jlr.M600551-JLR200Search in Google Scholar
Chatfield KC, Sparagna GC, Sucharov CC, Miyamoto SD, Grudis JE, Sobus RD, Hijmans J and Stauffer BL. Dysregulation of cardiolipin biosynthesis in pediatric heart failure. J Mol Cell Cardiol. 2014;74:251–9.ChatfieldKCSparagnaGCSucharovCCMiyamotoSDGrudisJESobusRDHijmansJStaufferBLDysregulation of cardiolipin biosynthesis in pediatric heart failure201474251910.1016/j.yjmcc.2014.06.002Search in Google Scholar
Saini-Chohan HK, Holmes MG, Chicco AJ, Taylor WA, Moore RL, McCune SA, Hickson-Bick DL, Hatch GM and Sparagna GC. Cardiolipin biosynthesis and remodeling enzymes are altered during development of heart failure. J Lipid Res. 2009;50:1600–8.Saini-ChohanHKHolmesMGChiccoAJTaylorWAMooreRLMcCuneSAHickson-BickDLHatchGMSparagnaGCCardiolipin biosynthesis and remodeling enzymes are altered during development of heart failure2009501600810.1194/jlr.M800561-JLR200Search in Google Scholar
Korshunov SS, Skulachev VP and Starkov AA. High protonic potential actuates a mechanism of production of reactive oxygen species in mitochondria. FEBS Lett. 1997;416:15–8.KorshunovSSSkulachevVPStarkovAAHigh protonic potential actuates a mechanism of production of reactive oxygen species in mitochondria199741615810.1016/S0014-5793(97)01159-9Search in Google Scholar
Frasier CR, Moore RL and Brown DA. Exercise-induced cardiac preconditioning: how exercise protects your achy-breaky heart. J Appl Physiol (1985). 2011;111:905–15.FrasierCRMooreRLBrownDAExercise-induced cardiac preconditioning: how exercise protects your achy-breaky heart20111119051510.1152/japplphysiol.00004.201121393468Search in Google Scholar
Marshall KD, Muller BN, Krenz M, Hanft LM, McDonald KS, Dellsperger KC and Emter CA. Heart failure with preserved ejection fraction: chronic low-intensity interval exercise training preserves myocardial O2 balance and diastolic function. J Appl Physiol (1985). 2013;114:131–47.MarshallKDMullerBNKrenzMHanftLMMcDonaldKSDellspergerKCEmterCAHeart failure with preserved ejection fraction: chronic low-intensity interval exercise training preserves myocardial O2 balance and diastolic function20131141314710.1152/japplphysiol.01059.2012354452023104696Search in Google Scholar
Flynn KE, Pina IL, Whellan DJ, Lin L, Blumenthal JA, Ellis SJ, Fine LJ, Howlett JG, Keteyian SJ, Kitzman DW, Kraus WE, Miller NH, Schulman KA, Spertus JA, O’Connor CM, Weinfurt KP and Investigators H-A. Effects of exercise training on health status in patients with chronic heart failure: HF-ACTION randomized controlled trial. JAMA. 2009;301:1451–9.FlynnKEPinaILWhellanDJLinLBlumenthalJAEllisSJFineLJHowlettJGKeteyianSJKitzmanDWKrausWEMillerNHSchulmanKASpertusJAO’ConnorCMWeinfurtKPInvestigators H-AEffects of exercise training on health status in patients with chronic heart failure: HF-ACTION randomized controlled trial20093011451910.1001/jama.2009.457269069919351942Search in Google Scholar
O’Connor CM, Whellan DJ, Lee KL, Keteyian SJ, Cooper LS, Ellis SJ, Leifer ES, Kraus WE, Kitzman DW, Blumenthal JA, Rendall DS, Miller NH, Fleg JL, Schulman KA, McKelvie RS, Zannad F, Pina IL and Investigators H-A. Efficacy and safety of exercise training in patients with chronic heart failure: HF-ACTION randomized controlled trial. JAMA. 2009;301:1439–50.O’ConnorCMWhellanDJLeeKLKeteyianSJCooperLSEllisSJLeiferESKrausWEKitzmanDWBlumenthalJARendallDSMillerNHFlegJLSchulmanKAMcKelvieRSZannadFPinaILInvestigators H-AEfficacy and safety of exercise training in patients with chronic heart failure: HF-ACTION randomized controlled trial200930114395010.1001/jama.2009.454291666119351941Search in Google Scholar
Edelmann F, Gelbrich G, Dungen HD, Frohling S, Wachter R, Stahrenberg R, Binder L, Topper A, Lashki DJ, Schwarz S, Herrmann-Lingen C, Loffler M, Hasenfuss G, Halle M and Pieske B. Exercise training improves exercise capacity and diastolic function in patients with heart failure with preserved ejection fraction: results of the Ex-DHF (Exercise training in Diastolic Heart Failure) pilot study. J Am Coll Cardiol. 2011;58:1780–91.EdelmannFGelbrichGDungenHDFrohlingSWachterRStahrenbergRBinderLTopperALashkiDJSchwarzSHerrmann-LingenCLofflerMHasenfussGHalleMPieskeBExercise training improves exercise capacity and diastolic function in patients with heart failure with preserved ejection fraction: results of the Ex-DHF (Exercise training in Diastolic Heart Failure) pilot study20115817809110.1016/j.jacc.2011.06.054Search in Google Scholar
Akhmedov AT, Rybin V and Marin-Garcia J. Mitochondrial oxidative metabolism and uncoupling proteins in the failing heart. Heart Fail Rev. 2015;20:227–49.AkhmedovATRybinVMarin-GarciaJMitochondrial oxidative metabolism and uncoupling proteins in the failing heart2015202274910.1007/s10741-014-9457-4Search in Google Scholar
Brand MD. Uncoupling to survive? The role of mitochondrial inefficiency in ageing. Exp Gerontol. 2000;35:811–20.BrandMDUncoupling to survive? The role of mitochondrial inefficiency in ageing2000358112010.1016/S0531-5565(00)00135-2Search in Google Scholar
Jones DP and Sies H. The Redox Code. Antioxidants & redox signaling. 2015;23:734–46.JonesDPSiesHThe Redox Code2015237344610.1089/ars.2015.6247458030825891126Search in Google Scholar
Karamanlidis G, Lee CF, Garcia-Menendez L, Kolwicz SC, Jr., Suthammarak W, Gong G, Sedensky MM, Morgan PG, Wang W and Tian R. Mitochondrial complex I deficiency increases protein acetylation and accelerates heart failure. Cell Metab. 2013;18:239–50.KaramanlidisGLeeCFGarcia-MenendezLKolwiczSCJr.SuthammarakWGongGSedenskyMMMorganPGWangWTianRMitochondrial complex I deficiency increases protein acetylation and accelerates heart failure2013182395010.1016/j.cmet.2013.07.002377964723931755Search in Google Scholar
Ronchi JA, Francisco A, Passos LA, Figueira TR and Castilho RF. The Contribution of Nicotinamide Nucleotide Transhydrogenase to Peroxide Detoxification Is Dependent on the Respiratory State and Counterbalanced by Other Sources of NADPH in Liver Mitochondria. The Journal of biological chemistry. 2016;291:20173–87.RonchiJAFranciscoAPassosLAFigueiraTRCastilhoRFThe Contribution of Nicotinamide Nucleotide Transhydrogenase to Peroxide Detoxification Is Dependent on the Respiratory State and Counterbalanced by Other Sources of NADPH in Liver Mitochondria2016291201738710.1074/jbc.M116.730473502570027474736Search in Google Scholar
Rydstrom J. Mitochondrial NADPH, transhydrogenase and disease. Biochimica et biophysica acta. 2006;1757:721–6.RydstromJMitochondrial NADPH, transhydrogenase and disease20061757721610.1016/j.bbabio.2006.03.01016730324Search in Google Scholar
Alano CC, Tran A, Tao R, Ying W, Karliner JS and Swanson RA. Differences among cell types in NAD(+) compartmentalization: a comparison of neurons, astrocytes, and cardiac myocytes. Journal of neuroscience research. 2007;85:3378–85.AlanoCCTranATaoRYingWKarlinerJSSwansonRADifferences among cell types in NAD(+) compartmentalization: a comparison of neurons, astrocytes, and cardiac myocytes20078533788510.1002/jnr.2147917853438Search in Google Scholar
Pillai VB, Sundaresan NR, Kim G, Gupta M, Rajamohan SB, Pillai JB, Samant S, Ravindra PV, Isbatan A and Gupta MP. Exogenous NAD blocks cardiac hypertrophic response via activation of the SIRT3-LKB1-AMP-activated kinase pathway. The Journal of biological chemistry. 2010;285:3133–44.PillaiVBSundaresanNRKimGGuptaMRajamohanSBPillaiJBSamantSRavindraPVIsbatanAGuptaMPExogenous NAD blocks cardiac hypertrophic response via activation of the SIRT3-LKB1-AMP-activated kinase pathway201028531334410.1074/jbc.M109.077271282345419940131Search in Google Scholar
Khanra R, Dewanjee S, T KD, Sahu R, Gangopadhyay M, De Feo V and Zia-Ul-Haq M. Abroma augusta L. (Malvaceae) leaf extract attenuates diabetes induced nephropathy and cardiomyopathy via inhibition of oxidative stress and inflammatory response. Journal of translational medicine. 2015;13:6.KhanraRDewanjeeSTKDSahuRGangopadhyayMDe FeoVZia-Ul-HaqMAbroma augusta L. (Malvaceae) leaf extract attenuates diabetes induced nephropathy and cardiomyopathy via inhibition of oxidative stress and inflammatory response201513610.1186/s12967-014-0364-1430189525591455Search in Google Scholar
Akie TE, Liu L, Nam M, Lei S and Cooper MP. OXPHOS-Mediated Induction of NAD+ Promotes Complete Oxidation of Fatty Acids and Interdicts Non-Alcoholic Fatty Liver Disease. PloS one. 2015;10:e0125617.AkieTELiuLNamMLeiSCooperMPOXPHOS-Mediated Induction of NAD+ Promotes Complete Oxidation of Fatty Acids and Interdicts Non-Alcoholic Fatty Liver Disease201510e012561710.1371/journal.pone.0125617441693125933096Search in Google Scholar
Wagner GR, Pride PM, Babbey CM and Payne RM. Friedreich’s ataxia reveals a mechanism for coordinate regulation of oxidative metabolism via feedback inhibition of the SIRT3 deacetylase. Human molecular genetics. 2012;21:2688–97.WagnerGRPridePMBabbeyCMPayneRMFriedreich’s ataxia reveals a mechanism for coordinate regulation of oxidative metabolism via feedback inhibition of the SIRT3 deacetylase20122126889710.1093/hmg/dds095336333622394676Search in Google Scholar
Sung HJ, Ma W, Wang PY, Hynes J, O’Riordan TC, Combs CA, McCoy JP, Jr., Bunz F, Kang JG and Hwang PM. Mitochondrial respiration protects against oxygen-associated DNA damage. Nature communications. 2010;1:5.SungHJMaWWangPYHynesJO’RiordanTCCombsCAMcCoyJPJr.BunzFKangJGHwangPMMitochondrial respiration protects against oxygen-associated DNA damage20101510.1038/ncomms1003339309320975668Search in Google Scholar
Horton JL, Martin OJ, Lai L, Riley NM, Richards AL, Vega RB, Leone TC, Pagliarini DJ, Muoio DM, Bedi KC, Jr., Margulies KB, Coon JJ and Kelly DP. Mitochondrial protein hyperacetylation in the failing heart. JCI insight. 2016;2.HortonJLMartinOJLaiLRileyNMRichardsALVegaRBLeoneTCPagliariniDJMuoioDMBediKCJr.MarguliesKBCoonJJKellyDPMitochondrial protein hyperacetylation in the failing heart2016210.1172/jci.insight.84897479583626998524Search in Google Scholar
Kouzu H, Miki T, Tanno M, Kuno A, Yano T, Itoh T, Sato T, Sunaga D, Murase H, Tobisawa T, Ogasawara M, Ishikawa S and Miura T. Excessive degradation of adenine nucleotides by up-regulated AMP deaminase underlies afterload-induced diastolic dysfunction in the type 2 diabetic heart. Journal of molecular and cellular cardiology. 2015;80:136–45.KouzuHMikiTTannoMKunoAYanoTItohTSatoTSunagaDMuraseHTobisawaTOgasawaraMIshikawaSMiuraTExcessive degradation of adenine nucleotides by up-regulated AMP deaminase underlies afterload-induced diastolic dysfunction in the type 2 diabetic heart2015801364510.1016/j.yjmcc.2015.01.00425599963Search in Google Scholar
Bhatt NM, Aon MA, Tocchetti CG, Shen X, Dey S, Ramirez-Correa G, O’Rourke B, Gao WD and Cortassa S. Restoring redox balance enhances contractility in heart trabeculae from type 2 diabetic rats exposed to high glucose. American journal of physiology Heart and circulatory physiology. 2015;308:H291–302.BhattNMAonMATocchettiCGShenXDeySRamirez-CorreaGO’RourkeBGaoWDCortassaSRestoring redox balance enhances contractility in heart trabeculae from type 2 diabetic rats exposed to high glucose2015308H29130210.1152/ajpheart.00378.2014432948125485897Search in Google Scholar
Imai S, Armstrong CM, Kaeberlein M and Guarente L. Transcriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase. Nature. 2000;403:795–800.ImaiSArmstrongCMKaeberleinMGuarenteLTranscriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase200040379580010.1038/3500162210693811Search in Google Scholar
Satoh A, Brace CS, Rensing N, Cliften P, Wozniak DF, Herzog ED, Yamada KA and Imai S. SIRT 1 extends life span and delays aging in mice through the regulation of Nk2 homeobox 1 in the DMH and LH. Cell metabolism. 2013;18:416–30.SatohABraceCSRensingNCliftenPWozniakDFHerzogEDYamadaKAImaiSSIRT 1 extends life span and delays aging in mice through the regulation of Nk2 homeobox 1 in the DMH and LH2013184163010.1016/j.cmet.2013.07.013379471224011076Search in Google Scholar
Cheng HL, Mostoslavsky R, Saito S, Manis JP, Gu Y, Patel P, Bronson R, Appella E, Alt FW and Chua KF. Developmental defects and p53 hyperacetylation in Sir2 homolog (SIRT 1)-deficient mice. Proceedings of the National Academy of Sciences of the United States of America. 2003;100:10794–9.ChengHLMostoslavskyRSaitoSManisJPGuYPatelPBronsonRAppellaEAltFWChuaKFDevelopmental defects and p53 hyperacetylation in Sir2 homolog (SIRT 1)-deficient mice200310010794910.1073/pnas.193471310019688212960381Search in Google Scholar
Alcendor RR, Gao S, Zhai P, Zablocki D, Holle E, Yu X, Tian B, Wagner T, Vatner SF and Sadoshima J. SIRT 1 regulates aging and resistance to oxidative stress in the heart. Circulation research. 2007;100:1512–21.AlcendorRRGaoSZhaiPZablockiDHolleEYuXTianBWagnerTVatnerSFSadoshimaJSIRT 1 regulates aging and resistance to oxidative stress in the heart200710015122110.1161/01.RES.0000267723.65696.4a17446436Search in Google Scholar
Nemoto S, Fergusson MM and Finkel T. SIRT 1 functionally interacts with the metabolic regulator and transcriptional coactivator PGC-1{alpha}. The Journal of biological chemistry. 2005;280:16456–60.NemotoSFergussonMMFinkelTSIRT 1 functionally interacts with the metabolic regulator and transcriptional coactivator PGC-1{alpha}2005280164566010.1074/jbc.M50148520015716268Search in Google Scholar
Gerhart-Hines Z, Rodgers JT, Bare O, Lerin C, Kim SH, Mostoslavsky R, Alt FW, Wu Z and Puigserver P. Metabolic control of muscle mitochondrial function and fatty acid oxidation through SIRT 1/PGC-1alpha. The EMBO journal. 2007;26:1913–23.Gerhart-HinesZRodgersJTBareOLerinCKimSHMostoslavskyRAltFWWuZPuigserverPMetabolic control of muscle mitochondrial function and fatty acid oxidation through SIRT 1/PGC-1alpha20072619132310.1038/sj.emboj.7601633184766117347648Search in Google Scholar
Lombard DB, Alt FW, Cheng HL, Bunkenborg J, Streeper RS, Mostoslavsky R, Kim J, Yancopoulos G, Valenzuela D, Murphy A, Yang Y, Chen Y, Hirschey MD, Bronson RT, Haigis M, Guarente LP, Farese RV, Jr., Weissman S, Verdin E and Schwer B. Mammalian Sir2 homolog SIRT3 regulates global mitochondrial lysine acetylation. Molecular and cellular biology. 2007;27:8807–14.LombardDBAltFWChengHLBunkenborgJStreeperRSMostoslavskyRKimJYancopoulosGValenzuelaDMurphyAYangYChenYHirscheyMDBronsonRTHaigisMGuarenteLPFareseRVJr.WeissmanSVerdinESchwerBMammalian Sir2 homolog SIRT3 regulates global mitochondrial lysine acetylation20072788071410.1128/MCB.01636-07216941817923681Search in Google Scholar
Koentges C, Pfeil K, Schnick T, Wiese S, Dahlbock R, Cimolai MC, Meyer-Steenbuck M, Cenkerova K, Hoffmann MM, Jaeger C, Odening KE, Kammerer B, Hein L, Bode C and Bugger H. SIRT3 deficiency impairs mitochondrial and contractile function in the heart. Basic research in cardiology. 2015;110:36.KoentgesCPfeilKSchnickTWieseSDahlbockRCimolaiMCMeyer-SteenbuckMCenkerovaKHoffmannMMJaegerCOdeningKEKammererBHeinLBodeCBuggerHSIRT3 deficiency impairs mitochondrial and contractile function in the heart20151103610.1007/s00395-015-0493-625962702Search in Google Scholar
Sundaresan NR, Gupta M, Kim G, Rajamohan SB, Isbatan A and Gupta MP. Sirt3 blocks the cardiac hypertrophic response by augmenting Foxo3a-dependent antioxidant defense mechanisms in mice. The Journal of clinical investigation. 2009;119:2758–71.SundaresanNRGuptaMKimGRajamohanSBIsbatanAGuptaMPSirt3 blocks the cardiac hypertrophic response by augmenting Foxo3a-dependent antioxidant defense mechanisms in mice200911927587110.1172/JCI39162273593319652361Search in Google Scholar
Jing E, O’Neill BT, Rardin MJ, Kleinridders A, Ilkeyeva OR, Ussar S, Bain JR, Lee KY, Verdin EM, Newgard CB, Gibson BW and Kahn CR. Sirt3 regulates metabolic flexibility of skeletal muscle through reversible enzymatic deacetylation. Diabetes. 2013;62:3404–17.JingEO’NeillBTRardinMJKleinriddersAIlkeyevaORUssarSBainJRLeeKYVerdinEMNewgardCBGibsonBWKahnCRSirt3 regulates metabolic flexibility of skeletal muscle through reversible enzymatic deacetylation20136234041710.2337/db12-1650378146523835326Search in Google Scholar
Ozden O, Park SH, Wagner BA, Yong Song H, Zhu Y, Vassilopoulos A, Jung B, Buettner GR and Gius D. SIRT3 deacetylates and increases pyruvate dehydrogenase activity in cancer cells. Free radical biology & medicine. 2014;76:163–72.OzdenOParkSHWagnerBAYong SongHZhuYVassilopoulosAJungBBuettnerGRGiusDSIRT3 deacetylates and increases pyruvate dehydrogenase activity in cancer cells2014761637210.1016/j.freeradbiomed.2014.08.001436430425152236Search in Google Scholar
Hirschey MD, Shimazu T, Goetzman E, Jing E, Schwer B, Lombard DB, Grueter CA, Harris C, Biddinger S, Ilkayeva OR, Stevens RD, Li Y, Saha AK, Ruderman NB, Bain JR, Newgard CB, Farese RV, Jr., Alt FW, Kahn CR and Verdin E. SIRT3 regulates mitochondrial fatty-acid oxidation by reversible enzyme deacetylation. Nature. 2010;464:121–5.HirscheyMDShimazuTGoetzmanEJingESchwerBLombardDBGrueterCAHarrisCBiddingerSIlkayevaORStevensRDLiYSahaAKRudermanNBBainJRNewgardCBFareseRVJr.AltFWKahnCRVerdinESIRT3 regulates mitochondrial fatty-acid oxidation by reversible enzyme deacetylation2010464121510.1038/nature08778284147720203611Search in Google Scholar
Hirschey MD, Shimazu T, Jing E, Grueter CA, Collins AM, Aouizerat B, Stancakova A, Goetzman E, Lam MM, Schwer B, Stevens RD, Muehlbauer MJ, Kakar S, Bass NM, Kuusisto J, Laakso M, Alt FW, Newgard CB, Farese RV, Jr., Kahn CR and Verdin E. SIRT3 deficiency and mitochondrial protein hyperacetylation accelerate the development of the metabolic syndrome. Molecular cell. 2011;44:177–90.HirscheyMDShimazuTJingEGrueterCACollinsAMAouizeratBStancakovaAGoetzmanELamMMSchwerBStevensRDMuehlbauerMJKakarSBassNMKuusistoJLaaksoMAltFWNewgardCBFareseRVJr.KahnCRVerdinESIRT3 deficiency and mitochondrial protein hyperacetylation accelerate the development of the metabolic syndrome2011441779010.1016/j.molcel.2011.07.019356343421856199Search in Google Scholar
Bharathi SS, Zhang Y, Mohsen AW, Uppala R, Balasubramani M, Schreiber E, Uechi G, Beck ME, Rardin MJ, Vockley J, Verdin E, Gibson BW, Hirschey MD and Goetzman ES. Sirtuin 3 (SIRT3) protein regulates long-chain acyl-CoA dehydrogenase by deacetylating conserved lysines near the active site. The Journal of biological chemistry. 2013;288:33837–47.BharathiSSZhangYMohsenAWUppalaRBalasubramaniMSchreiberEUechiGBeckMERardinMJVockleyJVerdinEGibsonBWHirscheyMDGoetzmanESSirtuin 3 (SIRT3) protein regulates long-chain acyl-CoA dehydrogenase by deacetylating conserved lysines near the active site2013288338374710.1074/jbc.M113.510354383712624121500Search in Google Scholar
Someya S, Yu W, Hallows WC, Xu J, Vann JM, Leeuwenburgh C, Tanokura M, Denu JM and Prolla TA. Sirt3 mediates reduction of oxidative damage and prevention of age-related hearing loss under caloric restriction. Cell. 2010;143:802–12.SomeyaSYuWHallowsWCXuJVannJMLeeuwenburghCTanokuraMDenuJMProllaTASirt3 mediates reduction of oxidative damage and prevention of age-related hearing loss under caloric restriction20101438021210.1016/j.cell.2010.10.002301884921094524Search in Google Scholar
Ahn BH, Kim HS, Song S, Lee IH, Liu J, Vassilopoulos A, Deng CX and Finkel T. A role for the mitochondrial deacetylase Sirt3 in regulating energy homeostasis. Proceedings of the National Academy of Sciences of the United States of America. 2008;105:14447–52.AhnBHKimHSSongSLeeIHLiuJVassilopoulosADengCXFinkelTA role for the mitochondrial deacetylase Sirt3 in regulating energy homeostasis2008105144475210.1073/pnas.0803790105256718318794531Search in Google Scholar
Smith CS, Bottomley PA, Schulman SP, Gerstenblith G and Weiss RG. Altered creatine kinase adenosine triphosphate kinetics in failing hypertrophied human myocardium. Circulation. 2006;114:1151–8.SmithCSBottomleyPASchulmanSPGerstenblithGWeissRGAltered creatine kinase adenosine triphosphate kinetics in failing hypertrophied human myocardium20061141151810.1161/CIRCULATIONAHA.106.613646180843816952984Search in Google Scholar
Weiss RG, Gerstenblith G and Bottomley PA. ATP flux through creatine kinase in the normal, stressed, and failing human heart. Proc Natl Acad Sci U S A. 2005;102:808–13.WeissRGGerstenblithGBottomleyPAATP flux through creatine kinase in the normal, stressed, and failing human heart20051028081310.1073/pnas.040896210254554615647364Search in Google Scholar
Phan TT, Abozguia K, Nallur Shivu G, Mahadevan G, Ahmed I, Williams L, Dwivedi G, Patel K, Steendijk P, Ashrafian H, Henning A and Frenneaux M. Heart failure with preserved ejection fraction is characterized by dynamic impairment of active relaxation and contraction of the left ventricle on exercise and associated with myocardial energy deficiency. J Am Coll Cardiol. 2009;54:402–9.PhanTTAbozguiaKNallur ShivuGMahadevanGAhmedIWilliamsLDwivediGPatelKSteendijkPAshrafianHHenningAFrenneauxMHeart failure with preserved ejection fraction is characterized by dynamic impairment of active relaxation and contraction of the left ventricle on exercise and associated with myocardial energy deficiency200954402910.1016/j.jacc.2009.05.01219628114Search in Google Scholar
Esposito A, De Cobelli F, Perseghin G, Pieroni M, Belloni E, Mellone R, Canu T, Gentinetta F, Scifo P, Chimenti C, Frustaci A, Luzi L, Maseri A and Maschio AD. Impaired left ventricular energy metabolism in patients with hypertrophic cardiomyopathy is related to the extension of fibrosis at delayed gadolinium-enhanced magnetic resonance imaging. Heart. 2009;95:228–33.EspositoADe CobelliFPerseghinGPieroniMBelloniEMelloneRCanuTGentinettaFScifoPChimentiCFrustaciALuziLMaseriAMaschioADImpaired left ventricular energy metabolism in patients with hypertrophic cardiomyopathy is related to the extension of fibrosis at delayed gadolinium-enhanced magnetic resonance imaging2009952283310.1136/hrt.2008.14256218708417Search in Google Scholar
Berthiaume JM, Kurdys JG, Muntean DM and Rosca MG. Mitochondrial NAD(+)/NADH Redox State and Diabetic Cardiomyopathy. Antioxid Redox Signal. 2019;30:375–398.BerthiaumeJMKurdysJGMunteanDMRoscaMGMitochondrial NAD(+)/NADH Redox State and Diabetic Cardiomyopathy20193037539810.1089/ars.2017.7415630667929073779Search in Google Scholar
Igarashi N, Nozawa T, Fujii N, Suzuki T, Matsuki A, Nakadate T, Igawa A and Inoue H. Influence of beta-adrenoceptor blockade on the myocardial accumulation of fatty acid tracer and its intracellular metabolism in the heart after ischemia-reperfusion injury. Circ J. 2006;70:1509–14.IgarashiNNozawaTFujiiNSuzukiTMatsukiANakadateTIgawaAInoueHInfluence of beta-adrenoceptor blockade on the myocardial accumulation of fatty acid tracer and its intracellular metabolism in the heart after ischemia-reperfusion injury20067015091410.1253/circj.70.150917062979Search in Google Scholar
Stanley WC, Morgan EE, Huang H, McElfresh TA, Sterk JP, Okere IC, Chandler MP, Cheng J, Dyck JR and Lopaschuk GD. Malonyl-CoA decarboxylase inhibition suppresses fatty acid oxidation and reduces lactate production during demand-induced ischemia. Am J Physiol Heart Circ Physiol. 2005;289:H2304–9.StanleyWCMorganEEHuangHMcElfreshTASterkJPOkereICChandlerMPChengJDyckJRLopaschukGDMalonyl-CoA decarboxylase inhibition suppresses fatty acid oxidation and reduces lactate production during demand-induced ischemia2005289H2304910.1152/ajpheart.00599.200516100246Search in Google Scholar
Fukushima A, Milner K, Gupta A and Lopaschuk GD. Myocardial Energy Substrate Metabolism in Heart Failure : from Pathways to Therapeutic Targets. Curr Pharm Des. 2015;21:3654–64.FukushimaAMilnerKGuptaALopaschukGDMyocardial Energy Substrate Metabolism in Heart Failure : from Pathways to Therapeutic Targets20152136546410.2174/138161282166615071015044526166604Search in Google Scholar
Kolwicz SC, Jr., Airhart S and Tian R. Ketones Step to the Plate: A Game Changer for Metabolic Remodeling in Heart Failure? Circulation. 2016;133:689–91.KolwiczSCJr.AirhartSTianRKetones Step to the Plate: A Game Changer for Metabolic Remodeling in Heart Failure?20161336899110.1161/CIRCULATIONAHA.116.021230482655926819375Search in Google Scholar
Bedi KC, Jr., Snyder NW, Brandimarto J, Aziz M, Mesaros C, Worth AJ, Wang LL, Javaheri A, Blair IA, Margulies KB and Rame JE. Evidence for Intramyocardial Disruption of Lipid Metabolism and Increased Myocardial Ketone Utilization in Advanced Human Heart Failure. Circulation. 2016;133:706–16.BediKCJr.SnyderNWBrandimartoJAzizMMesarosCWorthAJWangLLJavaheriABlairIAMarguliesKBRameJEEvidence for Intramyocardial Disruption of Lipid Metabolism and Increased Myocardial Ketone Utilization in Advanced Human Heart Failure20161337061610.1161/CIRCULATIONAHA.115.017545477933926819374Search in Google Scholar
Heart Outcomes Prevention Evaluation Study I, Yusuf S, Dagenais G, Pogue J, Bosch J and Sleight P. Vitamin E supplementation and cardiovascular events in high-risk patients. N Engl J Med. 2000;342:154–60.Heart Outcomes Prevention Evaluation Study IYusufSDagenaisGPogueJBoschJSleightPVitamin E supplementation and cardiovascular events in high-risk patients20003421546010.1056/NEJM20000120342030210639540Search in Google Scholar
Downey JM and Cohen MV. Why do we still not have cardioprotective drugs? Circ J. 2009;73:1171–7.DowneyJMCohenMVWhy do we still not have cardioprotective drugs?2009731171710.1253/circj.CJ-09-033819506318Search in Google Scholar
Escobales N, Nunez RE, Jang S, Parodi-Rullan R, Ayala-Pena S, Sacher JR, Skoda EM, Wipf P, Frontera W and Javadov S. Mitochondria-targeted ROS scavenger improves post-ischemic recovery of cardiac function and attenuates mitochondrial abnormalities in aged rats. J Mol Cell Cardiol. 2014;77:136–46.EscobalesNNunezREJangSParodi-RullanRAyala-PenaSSacherJRSkodaEMWipfPFronteraWJavadovSMitochondria-targeted ROS scavenger improves post-ischemic recovery of cardiac function and attenuates mitochondrial abnormalities in aged rats2014771364610.1016/j.yjmcc.2014.10.009431219425451170Search in Google Scholar
Liang HL, Sedlic F, Bosnjak Z and Nilakantan V. SOD1 and Mito-TEMPO partially prevent mitochondrial permeability transition pore opening, necrosis, and mitochondrial apoptosis after ATP depletion recovery. Free Radic Biol Med. 2010;49:1550–60.LiangHLSedlicFBosnjakZNilakantanVSOD1 and Mito-TEMPO partially prevent mitochondrial permeability transition pore opening, necrosis, and mitochondrial apoptosis after ATP depletion recovery20104915506010.1016/j.freeradbiomed.2010.08.018386311620736062Search in Google Scholar
Kawakami S, Matsuda A, Sunagawa T, Noda Y, Kaneko T, Tahara S, Hiraumi Y, Adachi S, Matsui H, Ando K, Fujita T, Maruyama N, Shirasawa T and Shimizu T. Antioxidant, EUK-8, prevents murine dilated cardiomyopathy. Circ J. 2009;73:2125–34.KawakamiSMatsudaASunagawaTNodaYKanekoTTaharaSHiraumiYAdachiSMatsuiHAndoKFujitaTMaruyamaNShirasawaTShimizuTAntioxidant, EUK-8, prevents murine dilated cardiomyopathy20097321253410.1253/circj.CJ-09-020419749480Search in Google Scholar
Breton M, Costemale-Lacoste JF, Li Z, Lafuente-Lafuente C, Belmin J and Mericskay M. Blood NAD levels are reduced in very old patients hospitalized for heart failure. Exp Gerontol. 2020;139:111051.BretonMCostemale-LacosteJFLiZLafuente-LafuenteCBelminJMericskayMBlood NAD levels are reduced in very old patients hospitalized for heart failure202013911105110.1016/j.exger.2020.11105132783906Search in Google Scholar
Diguet N, Trammell SAJ, Tannous C, Deloux R, Piquereau J, Mougenot N, Gouge A, Gressette M, Manoury B, Blanc J, Breton M, Decaux JF, Lavery GG, Baczko I, Zoll J, Garnier A, Li Z, Brenner C and Mericskay M. Nicotinamide Riboside Preserves Cardiac Function in a Mouse Model of Dilated Cardiomyopathy. Circulation. 2018;137:2256–2273.DiguetNTrammellSAJTannousCDelouxRPiquereauJMougenotNGougeAGressetteMManouryBBlancJBretonMDecauxJFLaveryGGBaczkoIZollJGarnierALiZBrennerCMericskayMNicotinamide Riboside Preserves Cardiac Function in a Mouse Model of Dilated Cardiomyopathy20181372256227310.1161/CIRCULATIONAHA.116.026099695468829217642Search in Google Scholar
Zhou B, Wang DD, Qiu Y, Airhart S, Liu Y, Stempien-Otero A, O’Brien KD and Tian R. Boosting NAD level suppresses inflammatory activation of PBMCs in heart failure. J Clin Invest. 2020;130:6054–6063.ZhouBWangDDQiuYAirhartSLiuYStempien-OteroAO’BrienKDTianRBoosting NAD level suppresses inflammatory activation of PBMCs in heart failure20201306054606310.1172/JCI138538759808132790648Search in Google Scholar
Lee CF, Chavez JD, Garcia-Menendez L, Choi Y, Roe ND, Chiao YA, Edgar JS, Goo YA, Goodlett DR, Bruce JE and Tian R. Normalization of NAD+ Redox Balance as a Therapy for Heart Failure. Circulation. 2016;134:883–94.LeeCFChavezJDGarcia-MenendezLChoiYRoeNDChiaoYAEdgarJSGooYAGoodlettDRBruceJETianRNormalization of NAD+ Redox Balance as a Therapy for Heart Failure20161348839410.1161/CIRCULATIONAHA.116.022495Search in Google Scholar
Bagul PK, Dinda AK and Banerjee SK. Effect of resveratrol on sirtuins expression and cardiac complications in diabetes. Biochemical and biophysical research communications. 2015;468:221–7.BagulPKDindaAKBanerjeeSKEffect of resveratrol on sirtuins expression and cardiac complications in diabetes2015468221710.1016/j.bbrc.2015.10.126Search in Google Scholar
Bagul PK, Deepthi N, Sultana R and Banerjee SK. Resveratrol ameliorates cardiac oxidative stress in diabetes through deacetylation of NFkB-p65 and histone 3. The Journal of nutritional biochemistry. 2015;26:1298–307.BagulPKDeepthiNSultanaRBanerjeeSKResveratrol ameliorates cardiac oxidative stress in diabetes through deacetylation of NFkB-p65 and histone 3201526129830710.1016/j.jnutbio.2015.06.006Search in Google Scholar
Bhatt JK, Thomas S and Nanjan MJ. Resveratrol supplementation improves glycemic control in type 2 diabetes mellitus. Nutrition research. 2012;32:537–41.BhattJKThomasSNanjanMJResveratrol supplementation improves glycemic control in type 2 diabetes mellitus2012325374110.1016/j.nutres.2012.06.003Search in Google Scholar
Liu K, Zhou R, Wang B and Mi MT. Effect of resveratrol on glucose control and insulin sensitivity: a meta-analysis of 11 randomized controlled trials. The American journal of clinical nutrition. 2014;99:1510–9.LiuKZhouRWangBMiMTEffect of resveratrol on glucose control and insulin sensitivity: a meta-analysis of 11 randomized controlled trials2014991510910.3945/ajcn.113.082024Search in Google Scholar
Tanno M, Kuno A, Yano T, Miura T, Hisahara S, Ishikawa S, Shimamoto K and Horio Y. Induction of manganese superoxide dismutase by nuclear translocation and activation of SIRT 1 promotes cell survival in chronic heart failure. The Journal of biological chemistry. 2010;285:8375–82.TannoMKunoAYanoTMiuraTHisaharaSIshikawaSShimamotoKHorioYInduction of manganese superoxide dismutase by nuclear translocation and activation of SIRT 1 promotes cell survival in chronic heart failure201028583758210.1074/jbc.M109.090266Search in Google Scholar
Beaudoin MS, Perry CG, Arkell AM, Chabowski A, Simpson JA, Wright DC and Holloway GP. Impairments in mitochondrial palmitoyl-CoA respiratory kinetics that precede development of diabetic cardiomyopathy are prevented by resveratrol in ZDF rats. The Journal of physiology. 2014;592:2519–33.BeaudoinMSPerryCGArkellAMChabowskiASimpsonJAWrightDCHollowayGPImpairments in mitochondrial palmitoyl-CoA respiratory kinetics that precede development of diabetic cardiomyopathy are prevented by resveratrol in ZDF rats201459225193310.1113/jphysiol.2013.270538Search in Google Scholar
Visarius TM, Stucki JW and Lauterburg BH. Inhibition and stimulation of long-chain fatty acid oxidation by chloroacetaldehyde and methylene blue in rats. The Journal of pharmacology and experimental therapeutics. 1999;289:820–4.VisariusTMStuckiJWLauterburgBHInhibition and stimulation of long-chain fatty acid oxidation by chloroacetaldehyde and methylene blue in rats19992898204Search in Google Scholar
Callaway NL, Riha PD, Bruchey AK, Munshi Z and Gonzalez-Lima F. Methylene blue improves brain oxidative metabolism and memory retention in rats. Pharmacology, biochemistry, and behavior. 2004;77:175–81.CallawayNLRihaPDBrucheyAKMunshiZGonzalez-LimaFMethylene blue improves brain oxidative metabolism and memory retention in rats2004771758110.1016/j.pbb.2003.10.007Search in Google Scholar
Callaway NL, Riha PD, Wrubel KM, McCollum D and Gonzalez-Lima F. Methylene blue restores spatial memory retention impaired by an inhibitor of cytochrome oxidase in rats. Neuroscience letters. 2002;332:83–6.CallawayNLRihaPDWrubelKMMcCollumDGonzalez-LimaFMethylene blue restores spatial memory retention impaired by an inhibitor of cytochrome oxidase in rats200233283610.1016/S0304-3940(02)00827-3Search in Google Scholar
Furian AF, Fighera MR, Oliveira MS, Ferreira AP, Fiorenza NG, de Carvalho Myskiw J, Petry JC, Coelho RC, Mello CF and Royes LF. Methylene blue prevents methylmalonate-induced seizures and oxidative damage in rat striatum. Neurochemistry international. 2007;50:164–71.FurianAFFigheraMROliveiraMSFerreiraAPFiorenzaNGde Carvalho MyskiwJPetryJCCoelhoRCMelloCFRoyesLFMethylene blue prevents methylmalonate-induced seizures and oxidative damage in rat striatum2007501647110.1016/j.neuint.2006.07.01216963161Search in Google Scholar
Kwok ES and Howes D. Use of methylene blue in sepsis: a systematic review. Journal of intensive care medicine. 2006;21:359–63.KwokESHowesDUse of methylene blue in sepsis: a systematic review2006213596310.1177/0885066606290671Search in Google Scholar
Clifton J, 2nd and Leikin JB. Methylene blue. American journal of therapeutics. 2003;10:289–91.CliftonJ2ndLeikinJBMethylene blue2003102899110.1097/00045391-200307000-00009Search in Google Scholar
Demirbilek S, Sizanli E, Karadag N, Karaman A, Bayraktar N, Turkmen E and Ersoy MO. The effects of methylene blue on lung injury in septic rats. European surgical research Europaische chirurgische Forschung. 2006;38:35–41.DemirbilekSSizanliEKaradagNKaramanABayraktarNTurkmenEErsoyMOThe effects of methylene blue on lung injury in septic rats200638354110.1159/000091525Search in Google Scholar
Riedel W, Lang U, Oetjen U, Schlapp U and Shibata M. Inhibition of oxygen radical formation by methylene blue, aspirin, or alpha-lipoic acid, prevents bacterial-lipopolysaccharide-induced fever. Molecular and cellular biochemistry. 2003;247:83–94.RiedelWLangUOetjenUSchlappUShibataMInhibition of oxygen radical formation by methylene blue, aspirin, or alpha-lipoic acid, prevents bacterial-lipopolysaccharide-induced fever2003247839410.1023/A:1024142400835Search in Google Scholar
Rezzani R, Rodella L, Corsetti G and Bianchi R. Does methylene blue protect the kidney tissues from damage induced by ciclosporin A treatment? Nephron. 2001;89:329–36.RezzaniRRodellaLCorsettiGBianchiRDoes methylene blue protect the kidney tissues from damage induced by ciclosporin A treatment?2001893293610.1159/000046094Search in Google Scholar
Hrushesky WJ, Olshefski R, Wood P, Meshnick S and Eaton JW. Modifying intracellular redox balance: an approach to improving therapeutic index. Lancet. 1985;1:565–7.HrusheskyWJOlshefskiRWoodPMeshnickSEatonJWModifying intracellular redox balance: an approach to improving therapeutic index19851565710.1016/S0140-6736(85)91218-8Search in Google Scholar
Haluzik M, Nedvidkova J and Skrha J. Treatment with the NO-synthase inhibitor, methylene blue, moderates the decrease in serum leptin concentration in streptozotocin-induced diabetes. Endocrine research. 1999;25:163–71.HaluzikMNedvidkovaJSkrhaJTreatment with the NO-synthase inhibitor, methylene blue, moderates the decrease in serum leptin concentration in streptozotocin-induced diabetes1999251637110.1080/07435809909066138Search in Google Scholar
Salaris SC, Babbs CF and Voorhees WD, 3rd. Methylene blue as an inhibitor of superoxide generation by xanthine oxidase. A potential new drug for the attenuation of ischemia/reperfusion injury. Biochemical pharmacology. 1991;42:499–506.SalarisSCBabbsCFVoorheesWD3rdMethylene blue as an inhibitor of superoxide generation by xanthine oxidase. A potential new drug for the attenuation of ischemia/reperfusion injury19914249950610.1016/0006-2952(91)90311-RSearch in Google Scholar
Rojas JC, John JM, Lee J and Gonzalez-Lima F. Methylene blue provides behavioral and metabolic neuroprotection against optic neuropathy. Neurotoxicity research. 2009;15:260–73.RojasJCJohnJMLeeJGonzalez-LimaFMethylene blue provides behavioral and metabolic neuroprotection against optic neuropathy2009152607310.1007/s12640-009-9027-z19384599Search in Google Scholar
Miclescu A, Basu S and Wiklund L. Methylene blue added to a hypertonic-hyperoncotic solution increases short-term survival in experimental cardiac arrest. Critical care medicine. 2006;34:2806–13.MiclescuABasuSWiklundLMethylene blue added to a hypertonic-hyperoncotic solution increases short-term survival in experimental cardiac arrest20063428061310.1097/01.CCM.0000242517.23324.2716957637Search in Google Scholar
Medina DX, Caccamo A and Oddo S. Methylene blue reduces abeta levels and rescues early cognitive deficit by increasing proteasome activity. Brain pathology (Zurich, Switzerland). 21:140–9.MedinaDXCaccamoAOddoSMethylene blue reduces abeta levels and rescues early cognitive deficit by increasing proteasome activity21140910.1111/j.1750-3639.2010.00430.xSearch in Google Scholar
O’Leary JC, 3rd, Li Q, Marinec P, Blair LJ, Congdon EE, Johnson AG, Jinwal UK, Koren J, 3rd, Jones JR, Kraft C, Peters M, Abisambra JF, Duff KE, Weeber EJ, Gestwicki JE and Dickey CA. Phenothiazine-mediated rescue of cognition in tau transgenic mice requires neuro-protection and reduced soluble tau burden. Molecular neurodegeneration. 5:45.O’LearyJC3rdLiQMarinecPBlairLJCongdonEEJohnsonAGJinwalUKKorenJ3rdJonesJRKraftCPetersMAbisambraJFDuffKEWeeberEJGestwickiJEDickeyCAPhenothiazine-mediated rescue of cognition in tau transgenic mice requires neuro-protection and reduced soluble tau burden54510.1186/1750-1326-5-45Search in Google Scholar
Wen Y, Li W, Poteet EC, Xie L, Tan C, Yan LJ, Ju X, Liu R, Qian H, Marvin MA, Goldberg MS, She H, Mao Z, Simpkins JW and Yang SH. Alternative mitochondrial electron transfer as a novel strategy for neuroprotection. The Journal of biological chemistry. 286:16504–15.WenYLiWPoteetECXieLTanCYanLJJuXLiuRQianHMarvinMAGoldbergMSSheHMaoZSimpkinsJWYangSHAlternative mitochondrial electron transfer as a novel strategy for neuroprotection286165041510.1074/jbc.M110.208447Search in Google Scholar
Gabrielli D, Belisle E, Severino D, Kowaltowski AJ and Baptista MS. Binding, aggregation and photochemical properties of methylene blue in mitochondrial suspensions. Photochemistry and photobiology. 2004;79:227–32.GabrielliDBelisleESeverinoDKowaltowskiAJBaptistaMSBinding, aggregation and photochemical properties of methylene blue in mitochondrial suspensions2004792273210.1562/BE-03-27.1Search in Google Scholar
Mellish KJ, Cox RD, Vernon DI, Griffiths J and Brown SB. In vitro photodynamic activity of a series of methylene blue analogues. Photochemistry and photobiology. 2002;75:392–7.MellishKJCoxRDVernonDIGriffithsJBrownSBIn vitro photodynamic activity of a series of methylene blue analogues200275392710.1562/0031-8655(2002)075<0392:IVPAOA>2.0.CO;2Search in Google Scholar
Tretter L, Horvath G, Holgyesi A, Essek F and Adam-Vizi V. Enhanced hydrogen peroxide generation accompanies the beneficial bioenergetic effects of methylene blue in isolated brain mitochondria. Free radical biology & medicine. 2014;77:317–30.TretterLHorvathGHolgyesiAEssekFAdam-ViziVEnhanced hydrogen peroxide generation accompanies the beneficial bioenergetic effects of methylene blue in isolated brain mitochondria2014773173010.1016/j.freeradbiomed.2014.09.024Search in Google Scholar
Mekala NK, Kurdys J, Depuydt MM, Vazquez EJ and Rosca MG. Apoptosis inducing factor deficiency causes retinal photoreceptor degeneration. The protective role of the redox compound methylene blue. Redox Biol. 2019;20:107–117.MekalaNKKurdysJDepuydtMMVazquezEJRoscaMGApoptosis inducing factor deficiency causes retinal photoreceptor degeneration. The protective role of the redox compound methylene blue20192010711710.1016/j.redox.2018.09.023Search in Google Scholar
Berthiaume JM, Hsiung CH, Austin AB, McBrayer SP, Depuydt MM, Chandler MP, Miyagi M and Rosca MG. Methylene blue decreases mitochondrial lysine acetylation in the diabetic heart. Mol Cell Biochem. 2017;432:7–24.BerthiaumeJMHsiungCHAustinABMcBrayerSPDepuydtMMChandlerMPMiyagiMRoscaMGMethylene blue decreases mitochondrial lysine acetylation in the diabetic heart201743272410.1007/s11010-017-2993-1Search in Google Scholar
Chouchani ET, Pell VR, Gaude E, Aksentijevic D, Sundier SY, Robb EL, Logan A, Nadtochiy SM, Ord ENJ, Smith AC, Eyassu F, Shirley R, Hu CH, Dare AJ, James AM, Rogatti S, Hartley RC, Eaton S, Costa ASH, Brookes PS, Davidson SM, Duchen MR, Saeb-Parsy K, Shattock MJ, Robinson AJ, Work LM, Frezza C, Krieg T and Murphy MP. Ischaemic accumulation of succinate controls reperfusion injury through mitochondrial ROS. Nature. 2014;515:431–435.ChouchaniETPellVRGaudeEAksentijevicDSundierSYRobbELLoganANadtochiySMOrdENJSmithACEyassuFShirleyRHuCHDareAJJamesAMRogattiSHartleyRCEatonSCostaASHBrookesPSDavidsonSMDuchenMRSaeb-ParsyKShattockMJRobinsonAJWorkLMFrezzaCKriegTMurphyMPIschaemic accumulation of succinate controls reperfusion injury through mitochondrial ROS201451543143510.1038/nature13909Search in Google Scholar
Molyneux SL, Florkowski CM, George PM, Pilbrow AP, Frampton CM, Lever M and Richards AM. Coenzyme Q10: an independent predictor of mortality in chronic heart failure. J Am Coll Cardiol. 2008;52:1435–41.MolyneuxSLFlorkowskiCMGeorgePMPilbrowAPFramptonCMLeverMRichardsAMCoenzyme Q10: an independent predictor of mortality in chronic heart failure20085214354110.1016/j.jacc.2008.07.044Search in Google Scholar
McMurray JJ, Dunselman P, Wedel H, Cleland JG, Lindberg M, Hjalmarson A, Kjekshus J, Waagstein F, Apetrei E, Barrios V, Bohm M, Kamensky G, Komajda M, Mareev V, Wikstrand J and Group CS. Coenzyme Q10, rosuvastatin, and clinical outcomes in heart failure: a pre-specified substudy of CORONA (controlled rosuvastatin multinational study in heart failure). J Am Coll Cardiol. 2010;56:1196–204.McMurrayJJDunselmanPWedelHClelandJGLindbergMHjalmarsonAKjekshusJWaagsteinFApetreiEBarriosVBohmMKamenskyGKomajdaMMareevVWikstrandJGroup CSCoenzyme Q10, rosuvastatin, and clinical outcomes in heart failure: a pre-specified substudy of CORONA (controlled rosuvastatin multinational study in heart failure)201056119620410.1016/j.jacc.2010.02.07520883926Search in Google Scholar
Mortensen SA, Rosenfeldt F, Kumar A, Dolliner P, Filipiak KJ, Pella D, Alehagen U, Steurer G, Littarru GP and Investigators QSS. The effect of coenzyme Q10 on morbidity and mortality in chronic heart failure: results from Q-SYMBIO: a randomized double-blind trial. JACC Heart Fail. 2014;2:641–9.MortensenSARosenfeldtFKumarADollinerPFilipiakKJPellaDAlehagenUSteurerGLittarruGPInvestigators QSSThe effect of coenzyme Q10 on morbidity and mortality in chronic heart failure: results from Q-SYMBIO: a randomized double-blind trial20142641910.1016/j.jchf.2014.06.00825282031Search in Google Scholar
Murphy MP. Targeting lipophilic cations to mitochondria. Biochim Biophys Acta. 2008;1777:1028–31.MurphyMPTargeting lipophilic cations to mitochondria2008177710283110.1016/j.bbabio.2008.03.02918439417Search in Google Scholar
Graham D, Huynh NN, Hamilton CA, Beattie E, Smith RA, Cocheme HM, Murphy MP and Dominiczak AF. Mitochondria-targeted antioxidant MitoQ10 improves endothelial function and attenuates cardiac hypertrophy. Hypertension. 2009;54:322–8.GrahamDHuynhNNHamiltonCABeattieESmithRACochemeHMMurphyMPDominiczakAFMitochondria-targeted antioxidant MitoQ10 improves endothelial function and attenuates cardiac hypertrophy200954322810.1161/HYPERTENSIONAHA.109.13035119581509Search in Google Scholar
Jaber S and Polster BM. Idebenone and neuroprotection: anti-oxidant, pro-oxidant, or electron carrier? J Bioenerg Biomembr. 2015;47:111–8.JaberSPolsterBMIdebenone and neuroprotection: anti-oxidant, pro-oxidant, or electron carrier?201547111810.1007/s10863-014-9571-y448781525262284Search in Google Scholar
El-Hattab AW, Zarante AM, Almannai M and Scaglia F. Therapies for mitochondrial diseases and current clinical trials. Mol Genet Metab. 2017;122:1–9.El-HattabAWZaranteAMAlmannaiMScagliaFTherapies for mitochondrial diseases and current clinical trials20171221910.1016/j.ymgme.2017.09.009577311328943110Search in Google Scholar
Buyse GM, Van der Mieren G, Erb M, D’Hooge J, Herijgers P, Verbeken E, Jara A, Van Den Bergh A, Mertens L, Courdier-Fruh I, Barzaghi P and Meier T. Long-term blinded placebo-controlled study of SNT-MC17/idebenone in the dystrophin deficient mdx mouse: cardiac protection and improved exercise performance. Eur Heart J. 2009;30:116–24.BuyseGMVan der MierenGErbMD’HoogeJHerijgersPVerbekenEJaraAVan Den BerghAMertensLCourdier-FruhIBarzaghiPMeierTLong-term blinded placebo-controlled study of SNT-MC17/idebenone in the dystrophin deficient mdx mouse: cardiac protection and improved exercise performance2009301162410.1093/eurheartj/ehn406263908618784063Search in Google Scholar
Lerman-Sagie T, Rustin P, Lev D, Yanoov M, Leshinsky-Silver E, Sagie A, Ben-Gal T and Munnich A. Dramatic improvement in mitochondrial cardiomyopathy following treatment with idebenone. J Inherit Metab Dis. 2001;24:28–34.Lerman-SagieTRustinPLevDYanoovMLeshinsky-SilverESagieABen-GalTMunnichADramatic improvement in mitochondrial cardiomyopathy following treatment with idebenone200124283410.1023/A:1005642302316Search in Google Scholar
Szeto HH. Mitochondria-targeted cytoprotective peptides for ischemia-reperfusion injury. Antioxid Redox Signal. 2008;10:601–19.SzetoHHMitochondria-targeted cytoprotective peptides for ischemia-reperfusion injury2008106011910.1089/ars.2007.189217999629Search in Google Scholar
Szeto HH, Liu S, Soong Y, Wu D, Darrah SF, Cheng FY, Zhao Z, Ganger M, Tow CY and Seshan SV. Mitochondria-targeted peptide accelerates ATP recovery and reduces ischemic kidney injury. J Am Soc Nephrol. 2011;22:1041–52.SzetoHHLiuSSoongYWuDDarrahSFChengFYZhaoZGangerMTowCYSeshanSVMitochondria-targeted peptide accelerates ATP recovery and reduces ischemic kidney injury20112210415210.1681/ASN.2010080808310372421546574Search in Google Scholar
Birk AV, Liu S, Soong Y, Mills W, Singh P, Warren JD, Seshan SV, Pardee JD and Szeto HH. The mitochondrial-targeted compound SS-31 re-energizes ischemic mitochondria by interacting with cardiolipin. J Am Soc Nephrol. 2013;24:1250–61.BirkAVLiuSSoongYMillsWSinghPWarrenJDSeshanSVPardeeJDSzetoHHThe mitochondrial-targeted compound SS-31 re-energizes ischemic mitochondria by interacting with cardiolipin20132412506110.1681/ASN.2012121216373670023813215Search in Google Scholar
Dai DF, Chen T, Szeto H, Nieves-Cintron M, Kutyavin V, Santana LF and Rabinovitch PS. Mitochondrial targeted antioxidant Peptide ameliorates hypertensive cardiomyopathy. J Am Coll Cardiol. 2011;58:73–82.DaiDFChenTSzetoHNieves-CintronMKutyavinVSantanaLFRabinovitchPSMitochondrial targeted antioxidant Peptide ameliorates hypertensive cardiomyopathy201158738210.1016/j.jacc.2010.12.044374201021620606Search in Google Scholar
Dai DF, Hsieh EJ, Chen T, Menendez LG, Basisty NB, Tsai L, Beyer RP, Crispin DA, Shulman NJ, Szeto HH, Tian R, MacCoss MJ and Rabinovitch PS. Global proteomics and pathway analysis of pressure-overload-induced heart failure and its attenuation by mitochondrial-targeted peptides. Circ Heart Fail. 2013;6:1067–76.DaiDFHsiehEJChenTMenendezLGBasistyNBTsaiLBeyerRPCrispinDAShulmanNJSzetoHHTianRMacCossMJRabinovitchPSGlobal proteomics and pathway analysis of pressure-overload-induced heart failure and its attenuation by mitochondrial-targeted peptides2013610677610.1161/CIRCHEARTFAILURE.113.000406385623823935006Search in Google Scholar
Shi J, Dai W, Hale SL, Brown DA, Wang M, Han X and Kloner RA. Bendavia restores mitochondrial energy metabolism gene expression and suppresses cardiac fibrosis in the border zone of the infarcted heart. Life Sci. 2015;141:170–8.ShiJDaiWHaleSLBrownDAWangMHanXKlonerRABendavia restores mitochondrial energy metabolism gene expression and suppresses cardiac fibrosis in the border zone of the infarcted heart2015141170810.1016/j.lfs.2015.09.022497330926431885Search in Google Scholar
Eirin A, Williams BJ, Ebrahimi B, Zhang X, Crane JA, Lerman A, Textor SC and Lerman LO. Mitochondrial targeted peptides attenuate residual myocardial damage after reversal of experimental renovascular hypertension. J Hypertens. 2014;32:154–65.EirinAWilliamsBJEbrahimiBZhangXCraneJALermanATextorSCLermanLOMitochondrial targeted peptides attenuate residual myocardial damage after reversal of experimental renovascular hypertension2014321546510.1097/HJH.0b013e3283658a53397656724048008Search in Google Scholar
Sabbah HN, Gupta RC, Kohli S, Wang M, Hachem S and Zhang K. Chronic Therapy With Elamipretide (MTP-131), a Novel Mitochondria-Targeting Peptide, Improves Left Ventricular and Mitochondrial Function in Dogs With Advanced Heart Failure. Circ Heart Fail. 2016;9:e002206.SabbahHNGuptaRCKohliSWangMHachemSZhangKChronic Therapy With Elamipretide (MTP-131), a Novel Mitochondria-Targeting Peptide, Improves Left Ventricular and Mitochondrial Function in Dogs With Advanced Heart Failure20169e00220610.1161/CIRCHEARTFAILURE.115.002206474354326839394Search in Google Scholar
Daubert MA, Yow E, Dunn G, Marchev S, Barnhart H, Douglas PS, O’Connor C, Goldstein S, Udelson JE and Sabbah HN. Novel Mitochondria-Targeting Peptide in Heart Failure Treatment: A Randomized, Placebo-Controlled Trial of Elamipretide. Circ Heart Fail. 2017;10.DaubertMAYowEDunnGMarchevSBarnhartHDouglasPSO’ConnorCGoldsteinSUdelsonJESabbahHNNovel Mitochondria-Targeting Peptide in Heart Failure Treatment: A Randomized, Placebo-Controlled Trial of Elamipretide20171010.1161/CIRCHEARTFAILURE.117.00438929217757Search in Google Scholar
Brown DA and O’Rourke B. Cardiac mitochondria and arrhythmias. Cardiovasc Res. 2010;88:241–9.BrownDAO’RourkeBCardiac mitochondria and arrhythmias201088241910.1093/cvr/cvq231298094320621924Search in Google Scholar
Kosmala W, Holland DJ, Rojek A, Wright L, Przewlocka-Kosmala M and Marwick TH. Effect of If-channel inhibition on hemodynamic status and exercise tolerance in heart failure with preserved ejection fraction: a randomized trial. J Am Coll Cardiol. 2013;62:1330–8.KosmalaWHollandDJRojekAWrightLPrzewlocka-KosmalaMMarwickTHEffect of If-channel inhibition on hemodynamic status and exercise tolerance in heart failure with preserved ejection fraction: a randomized trial2013621330810.1016/j.jacc.2013.06.04323916925Search in Google Scholar
Gorski PA, Ceholski DK and Hajjar RJ. Altered myocardial calcium cycling and energetics in heart failure–a rational approach for disease treatment. Cell Metab. 2015;21:183–194.GorskiPACeholskiDKHajjarRJAltered myocardial calcium cycling and energetics in heart failure–a rational approach for disease treatment20152118319410.1016/j.cmet.2015.01.005433899725651173Search in Google Scholar
Gong HB, Wang L, Lv Q and Wang J. Improved systolic function of rat cardiocytes during heart failure by overexpression of SERCA2a. Eur Rev Med Pharmacol Sci. 2016;20:1590–6.GongHBWangLLvQWangJImproved systolic function of rat cardiocytes during heart failure by overexpression of SERCA2a20162015906Search in Google Scholar
Mattila M, Koskenvuo J, Soderstrom M, Eerola K and Savontaus M. Intramyocardial injection of SERCA2a-expressing lentivirus improves myocardial function in doxorubicin-induced heart failure. J Gene Med. 2016;18:124–33.MattilaMKoskenvuoJSoderstromMEerolaKSavontausMIntramyocardial injection of SERCA2a-expressing lentivirus improves myocardial function in doxorubicin-induced heart failure2016181243310.1002/jgm.2885Search in Google Scholar
Greenberg B, Butler J, Felker GM, Ponikowski P, Voors AA, Desai AS, Barnard D, Bouchard A, Jaski B, Lyon AR, Pogoda JM, Rudy JJ and Zsebo KM. Calcium upregulation by percutaneous administration of gene therapy in patients with cardiac disease (CUPID 2): a randomised, multinational, double-blind, placebo-controlled, phase 2b trial. Lancet. 2016;387:1178–86.GreenbergBButlerJFelkerGMPonikowskiPVoorsAADesaiASBarnardDBouchardAJaskiBLyonARPogodaJMRudyJJZseboKMCalcium upregulation by percutaneous administration of gene therapy in patients with cardiac disease (CUPID 2): a randomised, multinational, double-blind, placebo-controlled, phase 2b trial201638711788610.1016/S0140-6736(16)00082-9Search in Google Scholar